The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 93

More JCP Articles

JCP
Original Research

May 7, 2019

Antidepressants are effective in preventing suicide, but some antidepressant-treated patients experience increased suicidal ideation. Read this article to learn if clinical features and biomarkers can predict worsened suicidal ideation…
, , , et al
JCP
Activating and Sedating Properties of Medications Used for MDD
Academic Highlights

April 30, 2019

Some antipsychotics used to treat MDD are associated with activating or sedating effects. In this Academic Highlights, 4 experts offer clinical insights into the impact of these effects on…
JCP
Original Research

April 30, 2019

Small-scale studies have shown that ADHD and severe psychiatric disorders are commonly clustered within families. Read this article to learn if this relationship held true in a large population-based…
, , , et al
JCP
Meta-Analysis

April 30, 2019

Methylphenidate is related to sleep-related adverse events. This meta-analysis sought to quantify this impact of methylphenidate and determine the varieties of sleep problems associated with this drug.
, , , et al
JCP
Letter to the Editor

April 24, 2019

, , , et al
JCP
Original Research

April 23, 2019

Developmental vulnerability for mental disorders exists in childhood and adolescence. Read this article to learn the incidences and risk factors of mental disorders across childhood and adolescence in a…
,
JCP
Original Research

April 23, 2019

Read a study examining if patients in the early phase of schizophrenia would accept LAI antipsychotic treatment.
, , , et al
JCP
Review Article

April 16, 2019

Intravenous ketamine has rapid and robust antidepressant effects. Read this systematic review to learn if oral ketamine also has efficacy and tolerability in depressed individuals.
, , , et al
JCP
Letter to the Editor

April 9, 2019

In this letter to the editor, Dr de Leon comments on the recent article “What Should a Psychiatrist Know About Genetics?” by Nurnberger et al.
JCP
Original Research

April 9, 2019

How bad is too bad? Lipid worsening of 5% or more in the early stages of treatment with SGAs predicts a negative metabolic outcome in adults. Is it the…
, , , et al
JCP
Letter to the Editor

April 9, 2019

Nurnberger and colleagues reply to the letter “Genetics Guideline Is Excellent, but the Pharmacogenetics Section Is Weak” by Jose de Leon.
, , , et al
JCP
Clinical and Practical Psychopharmacology

April 9, 2019

Read a study evaluating if orally administered ketamine is a more cost-effective and convenient alternative to other administration routes.

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe